G Reid

Summary

Affiliation: University of Western Ontario
Country: Canada

Publications

  1. ncbi Oral probiotics can resolve urogenital infections
    G Reid
    Lawson Research Institute, London, Ont, Canada
    FEMS Immunol Med Microbiol 30:49-52. 2001
  2. ncbi Identification and plasmid profiles of Lactobacillus species from the vagina of 100 healthy women
    G Reid
    Department of Microbiology and Immunology, University of Western Ontario, London, Canada
    FEMS Immunol Med Microbiol 15:23-6. 1996
  3. ncbi Can bacterial interference prevent infection?
    G Reid
    Lawson Health Research Institute, University of Western Ontario, 268 Grosvenor Street, London, Ontario, Canada N6A 4V2
    Trends Microbiol 9:424-8. 2001
  4. ncbi Probiotic agents to protect the urogenital tract against infection
    G Reid
    Lawson Research Institute and the Department of Microbiology and Immunology, The University of Western Ontario, Canada
    Am J Clin Nutr 73:437S-443S. 2001
  5. ncbi Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury
    G Reid
    Lawson Research Institute, London, Ont, Canada
    Int J Antimicrob Agents 13:305-7. 2000
  6. ncbi Potential preventive strategies and therapies in urinary tract infection
    G Reid
    Lawson Research Institute, London, Ontario, Canada
    World J Urol 17:359-63. 1999
  7. ncbi Asymptomatic bacteriuria in spinal cord patients and the elderly
    G Reid
    Department of Microbiology and Immunology, University of Western Ontario, Canada
    Urol Clin North Am 26:789-95. 1999
  8. ncbi Biofilms in infectious disease and on medical devices
    G Reid
    Department of Microbiology and Immunology, The University of Western Ontario, and Lawson Research Institute, London, Canada
    Int J Antimicrob Agents 11:223-6; discussion 237-9. 1999
  9. ncbi Biomaterials in Urology II: future usage and management
    G Reid
    Department of Microbiology and Immunology, The University of Western Ontario, London, Canada
    J Endourol 13:1-7. 1999
  10. ncbi Effect of nutrient composition on the in vitro growth of urogenital lactobacilli and uropathogens
    G Reid
    Department of Microbiology and Immunology, University of Western Ontario, London, Canada
    Can J Microbiol 44:866-71. 1998

Collaborators

Detail Information

Publications26

  1. ncbi Oral probiotics can resolve urogenital infections
    G Reid
    Lawson Research Institute, London, Ont, Canada
    FEMS Immunol Med Microbiol 30:49-52. 2001
    ..In six cases of asymptomatic BV or intermediate BV (based upon Nugent scoring) was resolved within 1 week of therapy...
  2. ncbi Identification and plasmid profiles of Lactobacillus species from the vagina of 100 healthy women
    G Reid
    Department of Microbiology and Immunology, University of Western Ontario, London, Canada
    FEMS Immunol Med Microbiol 15:23-6. 1996
    ..Of the strains tested, few were resistant to the spermicidal agent nonoxynol-9. The data identify species within which strains may possess properties associated with maintenance of a healthy vaginal ecology...
  3. ncbi Can bacterial interference prevent infection?
    G Reid
    Lawson Health Research Institute, University of Western Ontario, 268 Grosvenor Street, London, Ontario, Canada N6A 4V2
    Trends Microbiol 9:424-8. 2001
    ..The potential for new therapeutic regimens using probiotics is significant and worthy of further study...
  4. ncbi Probiotic agents to protect the urogenital tract against infection
    G Reid
    Lawson Research Institute and the Department of Microbiology and Immunology, The University of Western Ontario, Canada
    Am J Clin Nutr 73:437S-443S. 2001
    ....
  5. ncbi Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury
    G Reid
    Lawson Research Institute, London, Ont, Canada
    Int J Antimicrob Agents 13:305-7. 2000
    ..24%) (P=0.005) and day 7 (67 vs. 35%) (P=0.014). The study showed that ofloxacin was better than TMPSMX and alternatives at relieving clinical infection and eradicating bladder cell biofilms...
  6. ncbi Potential preventive strategies and therapies in urinary tract infection
    G Reid
    Lawson Research Institute, London, Ontario, Canada
    World J Urol 17:359-63. 1999
    ..The next decade should see the introduction of new methods for reduction of the high incidence of UTI and better management of recurring urogenital infections...
  7. ncbi Asymptomatic bacteriuria in spinal cord patients and the elderly
    G Reid
    Department of Microbiology and Immunology, University of Western Ontario, Canada
    Urol Clin North Am 26:789-95. 1999
    ....
  8. ncbi Biofilms in infectious disease and on medical devices
    G Reid
    Department of Microbiology and Immunology, The University of Western Ontario, and Lawson Research Institute, London, Canada
    Int J Antimicrob Agents 11:223-6; discussion 237-9. 1999
    ..For the treating physician, many antibiotics are unable to eradicate dense biofilms, and therefore much work is required to devise ways to prevent their occurrence and clear them from the host...
  9. ncbi Biomaterials in Urology II: future usage and management
    G Reid
    Department of Microbiology and Immunology, The University of Western Ontario, London, Canada
    J Endourol 13:1-7. 1999
    ..By necessity, some of these citations are speculative, but supporting documentation for their inclusion is presented...
  10. ncbi Effect of nutrient composition on the in vitro growth of urogenital lactobacilli and uropathogens
    G Reid
    Department of Microbiology and Immunology, University of Western Ontario, London, Canada
    Can J Microbiol 44:866-71. 1998
    ..These in vitro results provide a basis for testing nutritional supplements to alter the urogenital flora in an attempt to enhance restoration and maintenance of a normal disease-free state...
  11. ncbi Uropathogenic Escherichia coli adhere to urinary catheters without using fimbriae
    G Reid
    Department of Microbiology and Immunology, University of Western Ontario, London, Canada
    FEMS Immunol Med Microbiol 16:159-62. 1996
    ....
  12. ncbi Could probiotics be an option for treating and preventing urogenital infections?
    G Reid
    Lawson Health Research Institute and Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada
    Medscape Womens Health 6:9. 2001
    ..Although few strains have been selected and targeted for urogenital applications, and none are currently available on the market, evidence shows that probiotic therapy has the potential to make an impact on women's health...
  13. ncbi Urogenital infections in women: can probiotics help?
    G Reid
    Department of Microbiology and Immunology, University of Western Ontario and Canadian Research and Development Centre for Probiotics, Lawson Health Research Institute, London, Ontario, Canada
    Postgrad Med J 79:428-32. 2003
    ..The role of the intestinal, vaginal, and urethral flora and probiotics in urogenital health will be the focus of this review...
  14. ncbi Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora
    G Reid
    H414, Lawson Health Research Institute, University of Western Ontario, London, ON, Canada
    FEMS Immunol Med Microbiol 32:37-41. 2001
    ..This study confirms the potential efficacy of orally administered lactobacilli as a non-chemotherapeutic means to restore and maintain a normal urogenital flora, and shows that over 10(8) viable organisms per day is the required dose...
  15. ncbi Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation
    G Reid
    Division of Urology, Lawson Health Research Institute, 268 Grosvenor Street, Ont, N6A 4V2, London, Canada
    Int J Antimicrob Agents 17:317-9; discussion 319-20. 2001
    ..If biomaterial properties can be enhanced to increase further the adsorptive concentration of drug, the risk of infections and recalcitrant biofilm formation could be significantly reduced in a highly susceptible patient population...
  16. ncbi Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli
    P A Cadieux
    Canadian Research and Development Centre for Probiotics, Lawson Health Research Institute, London, Canada
    J Physiol Pharmacol 60:13-8. 2009
    ..Our findings indicate that compounds secreted by lactobacilli likely protect the urogenital tract from UPEC colonization and infection by inhibiting growth, inducing stress and downregulating proteins critical for host attachment...
  17. ncbi Advances in ureteral stent technology
    J D Denstedt
    Division of Urology, The University of Western Ontario, St Joseph s Health Care London, 268 Grosvenor Street, London, Ontario, Canada
    World J Urol 18:237-42. 2000
    ..Just so, encrustation limits the long-term use of urinary materials, and a better understanding of factors involved in encrustation are needed to reduce the problem...
  18. ncbi Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured patients
    G Reid
    Lawson Health Research Institute, London, Ontario, Canada
    Spinal Cord 39:26-30. 2001
    ..SPONSORSHIP: This study was funded by Ocean Spray Cranberries, Lakeville, MA, USA...
  19. ncbi Opinion paper: Quo vadis - EFSA?
    G Reid
    Lawson Health Research Institute, Canadian Research and Development Centre for Probiotics, London N6A 4V2 Ontario, Canada
    Benef Microbes 2:177-81. 2011
    ..The recent rejection of a simple and quite bland claim related to vaginal health emphasises the travesty of this bureaucracy. Herein, the science fights back and counters the critique of EFSA...
  20. ncbi Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients
    M Lorea Baroja
    Canadian Research and Development Centre for Probiotics, The Lawson Health Research Institute, London, Ontario, Canada
    Clin Exp Immunol 149:470-9. 2007
    ..Probiotic yogurt intake was associated with significant anti-inflammatory effects that paralleled the expansion of peripheral pool of putative T(reg) cells in IBD patients and with few effects in controls...
  21. ncbi Detection of Bifidobacterium species and Gardnerella vaginalis in the vagina using PCR and denaturing gradient gel electrophoresis (DGGE)
    J P Burton
    The Lawson Health Research Institute, St. Joseph's Hospital, London, Ontario, Canada
    Int J Gynaecol Obstet 81:61-3. 2003
  22. ncbi Research priorities for urological care following spinal cord injury: recommendations of an expert panel
    K C Hayes
    The Ontario Neurotrauma Foundation International Expert Panel, Ontario, Canada
    Can J Urol 14:3416-23. 2007
    ....
  23. ncbi Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend?
    G Reid
    Department of Microbiology, University of Western Ontario, London, Canada
    Can J Gastroenterol 22:169-75. 2008
    ..In due course, more clinically documented probiotics will emerge, some with therapeutic effects based on a better understanding of disease processes...
  24. ncbi Gut flora in health and disease: potential role of probiotics
    M Heselmans
    Lawson Health and Research Institute, University of Western Ontario, London, Ontario, Canada
    Curr Issues Intest Microbiol 6:1-7. 2005
    ..Besides, more clinical studies are required to convince authorities and the public of the value of microbial therapies...
  25. ncbi Probiotics and nutrients for the first 1000 days of life in the developing world
    M K Enos
    Canadian Research and Development Centre for Probiotics, F2 116, The Lawson Health Research Institute, 268 Grosvenor Street, London, ON N6A 4V2, Canada
    Benef Microbes 4:3-16. 2013
    ....
  26. ncbi Digoxigenin-labelled peptide nucleic acid to detect lactobacilli PCR amplicons immobilized on membranes from denaturing gradient gel electrophoresis
    J P Burton
    Canadian Research and Development Center for Probiotics, The Lawson Health Research Institute, Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada
    Lett Appl Microbiol 36:145-9. 2003
    ....